Oracle LSC Designer 7.0.1.0 Platform HTTP Unauth CVE-2026-21970
CVE-2026-21970 Published on January 20, 2026

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

Vendor Advisory NVD

Vulnerability Analysis

CVE-2026-21970 is exploitable with network access, and requires small amount of user privileges. This vulnerability is considered to have a low attack complexity. The potential impact of an exploit of this vulnerability is considered to have a high impact on confidentiality, with no impact on integrity and availability.

Attack Vector:
NETWORK
Attack Complexity:
LOW
Privileges Required:
LOW
User Interaction:
NONE
Scope:
UNCHANGED
Confidentiality Impact:
HIGH
Integrity Impact:
NONE
Availability Impact:
NONE

Products Associated with CVE-2026-21970

stack.watch emails you whenever new vulnerabilities are published in Oracle or Oracle Life Sciences Central Designer. Just hit a watch button to start following.

Oracle
 
Oracle Life Sciences Central Designer
 

Affected Versions

Oracle Corporation Oracle Life Sciences Central Designer Version 7.0.1.0 is affected by CVE-2026-21970

Exploit Probability

EPSS
0.05%
Percentile
14.26%

EPSS (Exploit Prediction Scoring System) scores estimate the probability that a vulnerability will be exploited in the wild within the next 30 days. The percentile shows you how this score compares to all other vulnerabilities.